Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Katkó Mónika

University of Debrecen Faculty of Medicine

Department of Internal Medicine

2005-

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2006-2025

2025

Galgóczi, E., Katkó, M., Borbély, S., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Agarose Gel Electrophoresis Reveals the Molecular Weight Distribution of Hyaluronan Produced by Orbital Fibroblasts.
Gels. 11 (6), 1-15, (article identifier: 406), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Bioengineering

Q2 Biomaterials

Q1 Organic Chemistry

Q1 Polymers and Plastics

Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., Berta, E.: Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.
Biomedicines. 13 (2), 1-16, (article identifier: 438), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

Cogoi, B., Esze, R., Somodi, S., Shemirani, A. H., Bereczky, Z., Muszbek, L., Paragh, G., Katkó, M., Káplár, M.: Protective Effect of Factor XIII Intron-K G Allele on Subclinical Vascular Disease.
Int. J. Mol. Sci. 26 (21), 1-13, (article identifier: 10293), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Stimulation of Piezo1 Mechanosensitive Channels Inhibits Adipogenesis in Thyroid Eye Disease.
J. Clin. Endocrinol. Metab. 110 (9), 2584-2594, 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry

D1 Biochemistry (medical)

D1 Clinical Biochemistry

D1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

D1 Medicine (miscellaneous)

2024

Papp, F. R., Csiki, R., Katkó, M., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts.
EJEA. 101, 20, 2024.

doi DEA

Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (article identifier: 13), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

Galgóczi, E., Molnár, Z., Katkó, M., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
Chem.-Biol. Interact. 396, 1-7, (article identifier: 111045), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Toxicology

Q1 Medicine (miscellaneous)

Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.

DEA

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Endocrinology, Diabetes and Metabolism

Q2 Molecular Biology

10.

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts.
EJEA. 101, 37, (article identifier: 0101), 2024.

doi DEA

11.

Sinkó, R., Katkó, M., Tóth, G., Kovács, G. L., Dohán, O., Fülöp, T., Costa, P., Dorogházi, B., Kővári, D., Nagy, E. V., Fekete, C., Gereben, B.: Novel biomarkers reveal mismatch between tissue and serum thyroid hormone status in amiodarone-induced hyperthyroidism.
J. Clin. Endocrinol. Metab. 110 (2), 374-386, 2024.

doi DEA Scopus

Journal metrics:

D1 Biochemistry

D1 Biochemistry (medical)

D1 Clinical Biochemistry

D1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

D1 Medicine (miscellaneous)

12.

Csiki, R., Papp, F. R., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V., Katkó, M.: Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation.
EJEA. 101, 38, 2024.

doi DEA

2023

13.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (article identifier: 1187725), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

14.

Kerekes, G., Bodoki, M., Hamar, A. B., Karancsiné Pusztai, A., Tajti, G., Katkó, M., Végh, E., Pethő, Z., Bodnár, N., Horváth, Á., Soós, B., Szamosi, S., Hascsi, Z., Harangi, M., Hódosi, K., Panyi, G., Seres, T., Szűcs, G., Szekanecz, Z.: Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
RHEUMATOLOGY. 62 (SI3), SI304-SI312, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmacology (medical)

D1 Rheumatology

2022

15.

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

DEA WoS Scopus

Journal metrics:

Q4 Endocrine and Autonomic Systems

Q4 Endocrinology

Q4 Endocrinology, Diabetes and Metabolism

Q4 Medicine (miscellaneous)

Q4 Neurology

Q4 Neurology (clinical)

Q4 Psychiatry and Mental Health

16.

Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81, EP400, 2022.

doi DEA

17.

Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E. V., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355, e247-e248, 2022.

doi DEA

18.

Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

19.

Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, (article identifier: 15), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

20.

Taybani, Z., Bótyik, B., Gyimesi, A., Katkó, M., Várkonyi, T.: One-year safety and efficacy results of insulin treatment simplification with in type 2 diabetes.
Endocrino Diabet & Metabol. 6 (1), 1-7, (article identifier: 390), 2022.

doi DEA Scopus

21.

Lőrincz, H., Galgóczi, E., Katkó, M., Ratku, B., Ötvös, T., Harangi, M., Paragh, G., Szabó, Z., Somodi, S.: Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G/5G polymorphism dependent manner.
Atherosclerosis. 355, e248, 2022.

doi DEA

22.

Cogoi, B., Esze, R., Rajnai, L., Somodi, S., Shemirani, A. H., Bereczky, Z., Paragh, G., Katkó, M., Káplár, M.: Protective effect of factor XIII Intron-K G allele on subclinical atherosclerosis.

DEA

23.

Galgóczi, E., Katkó, M., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: The effect of glucocorticoids on hyaluronan production of orbital fibroblasts.
Endocrine Abst. 84, PS2-07-64, 2022.

doi DEA

24.

Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H. P., Nagy, E. V.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355, e163, 2022.

doi DEA

2021

25.

Sztanek, F., Demeter, Z., Katkó, M., Molnár, Á., Jakab, A. Á., Harangi, M.: A diabeteses autonóm neuropathia vizsgálata a Debreceni Egyetem Diabeteses Neuropathia Centrum betegeinek körében kérdőíves módszer segítségével.
Diabetol. Hung. 29 (1), 39-46, 2021.

doi DEA